Results for ALPS

1 - 7 of 7

Dr. Grupp develops and conducts preclinical testing of engineered cell therapies and signal transduction inhibitors in leukemia, in pediatric immunotherapy trials, and in the manufacture and use of cellular therapeutics in preclinical, good manufacturing practices, and clinical trial settings. Dr. Grupp leads most CTL019 (CD19 CAR) clinical trials, and his colleagues are the global leaders in highly active CAR T cell therapy.

E-mail:

grupp [at] chop.edu

David T. Teachey, MD

Dr. Teachey's research focuses on investigating novel therapeutics for children with white blood cell diseases, including ALL and a rare autoimmune disease called Autoimmune Lymphoproliferative Syndrome (ALPS). His research in ALL focuses on studying leukemic cells from children with high-risk disease.

E-mail:

teacheyd [at] chop.edu

Sharon McGrath-Morrow, MBA, MD

Dr. McGrath-Morrow is associate chief of the Division of Pulmonary and Sleep Medicine and leader of the Post-preemie Lung Disease Clinic at Children’s Hospital of Philadelphia. Her research seeks to link early life events with adult lung health and biomarker discovery for future trials.

E-mail:

mcgrathmos [at] chop.edu

Women’s History Month: Q&A With Featured Research Trainee, Sakshi Arora, PhD

Published on

Mar 2, 2021

in Cornerstone Blog

Women’s History Month: Q&A With Sakshi Arora

Our March Featured Research Trainee, Sakshi Arora, reflects on Women’s History Month and her scientific career.

Off Campus: Above the Clouds at 20,000 Feet

Published on

Sep 4, 2020

in Cornerstone Blog

CHOP investigator, Akiva Cohen, PhD, spends his days researching concussions, but once he leaves his lab, his head is in the clouds.

Drug Trial Shows "Profound" Success Treating Rare Blood Disorders

Published on

Nov 3, 2015

in Cornerstone Blog

When the immune system inappropriately destroys blood cells, in a relatively rare group of diseases called autoimmune cytopenias, children may suffer for years with anemia, uncontrolled bleeding, and vulnerability to infections, while their parents struggle to find a diagnosis.

Teachey Laboratory

The Teachey Lab studies perturbations in leukemic cell signal transduction pathways with the aim of identifying targeted cancer inhibitors and immunotherapies that can treat children with high-risk leukemias and autoimmune lymphoproliferative syndrome.